UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemic obesity in children and adolescents: risk factors and prevention

Frontiers of medicine, 2018-12, Vol.12 (6), p.658-666

2018

Volltextzugriff (PDF)

Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study

European heart journal, 2017-12, Vol.38 (48), p.3560-3566

2017

Volltextzugriff (PDF)

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

The Lancet (British edition), 2013-09, Vol.382 (9896), p.941-950

2013

Volltextzugriff (PDF)

β cell replacement therapy for the cure of diabetes

Journal of diabetes investigation, 2022-11, Vol.13 (11), p.1798-1802

2022

Volltextzugriff (PDF)

Advancements and challenges in pancreatic islet transplantation: Insights from the Collaborative Islet Transplant Registry

Journal of diabetes investigation, 2024-04, Vol.15 (4), p.423-425

2024

Volltextzugriff (PDF)

Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding study

Diabetes, obesity & metabolism, 2020-07, Vol.22 (7), p.1176-1186

2020

Volltextzugriff (PDF)

Fighting the uphill battle to cure type 1 diabetes

Journal of diabetes investigation, 2021-09, Vol.12 (9), p.1542-1544

2021

Volltextzugriff (PDF)

An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer

Nature communications, 2021-01, Vol.12 (1), p.183-183, Article 183

2021

Volltextzugriff (PDF)

Pharmacokinetic and dose‐finding studies on efpeglenatide in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2020-08, Vol.22 (8), p.1292-1301

2020

Volltextzugriff (PDF)

Effect of sodium‐glucose cotransporter 2 inhibitor, empagliflozin, and α‐glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes

Journal of cellular biochemistry, 2019-05, Vol.120 (5), p.8534-8546

2019

Volltextzugriff (PDF)

Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study

PloS one, 2014-02, Vol.9 (2), p.e90430-e90430

2014

Volltextzugriff (PDF)

Islet transplantation in Korea

Journal of diabetes investigation, 2024-09, Vol.15 (9), p.1165-1170

2024

Volltextzugriff (PDF)

Epidemic obesity and type 2 diabetes in Asia

The Lancet (British edition), 2006-11, Vol.368 (9548), p.1681-1688

2006

Volltextzugriff (PDF)

Use of sodium‐glucose co‐transporter‐2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations

Diabetes, obesity & metabolism, 2021-02, Vol.23 (2), p.299-317

2021

Volltextzugriff (PDF)

The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention

International journal of cardiology, 2017-08, Vol.241, p.57-63

2017

Volltextzugriff (PDF)

Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study

Diabetes, obesity & metabolism, 2019-11, Vol.21 (11), p.2429-2439

2019

Volltextzugriff (PDF)

Prepregnancy smoking and the risk of gestational diabetes requiring insulin therapy

Scientific reports, 2020-08, Vol.10 (1), p.13901-13901, Article 13901

2020

Volltextzugriff (PDF)

Diabetes duration and obesity matter in autologous mesenchymal stem/stromal cell transplantation in type 2 diabetes patients

Journal of diabetes investigation, 2022-02, Vol.13 (2), p.230-232

2022

Volltextzugriff (PDF)

Being caught in the perfect storm of a diabetes epidemic and the COVID‐19 pandemic: What should we do for our patients?

Journal of diabetes investigation, 2021-03, Vol.12 (3), p.297-300

2021

Volltextzugriff (PDF)

HDL-cholesterol, its variability and the risk of diabetes : a nationwide population-based study

The journal of clinical endocrinology and metabolism, 2019-11, Vol.104 (11), p.5633-5641

2019

Volltextzugriff (PDF)

Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes

Lipids in health and disease, 2016-09, Vol.15 (1), p.155-155, Article 155

2016

Volltextzugriff (PDF)

Risk of developing chronic kidney disease in young-onset Type 2 diabetes in Korea

Scientific reports, 2023-06, Vol.13 (1), p.10100-10100, Article 10100

2023

Volltextzugriff (PDF)

A Century of Progress in Diabetes Care with Insulin: A History of Innovations and Foundation for the Future

Diabetes and Metabolism Journal, 2021, 45(5), 187, pp.629-640

2021

Volltextzugriff (PDF)

A 52‐week efficacy and safety study of enavogliflozin versus dapagliflozin as an add‐on to metformin in patients with type 2 diabetes mellitus: ENHANCE‐M extension study

Diabetes, obesity & metabolism, 2024-06, Vol.26 (6), p.2248-2256

2024

Volltextzugriff (PDF)

Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record–Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial

Journal of medical Internet research, 2022-07, Vol.24 (7), p.e37430-e37430

2022

Volltextzugriff (PDF)

1 – 25 von 602

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(520)
Mit Volltextzugriff
(541)

Publikationsform

Sprache

Englisch
(465)
Koreanisch
(128)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(327)
Life Sciences & Biomedicine
(295)
Humans
(197)
Endocrinology & Metabolism
(163)
Male
(162)
Diabetes Mellitus
(143)
Female
(137)
Middle Aged
(125)
Diabetes
(96)
Aged
(92)
Adult
(81)
Animals
(71)
Original
(68)
내과학
(64)
Risk Factors
(53)
Diabetes Mellitus, Type 2 - Drug Therapy
(47)
Biological And Medical Sciences
(44)
Glucose
(42)
Type 2 Diabetes
(41)
Body Mass Index
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Epidemic obesity in children and adolescents: risk factors and prevention

Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

β cell replacement therapy for the cure of diabetes

Advancements and challenges in pancreatic islet transplantation: Insights from the Collaborative Islet Transplant Registry

Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding study

Fighting the uphill battle to cure type 1 diabetes

An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer

Pharmacokinetic and dose‐finding studies on efpeglenatide in patients with type 2 diabetes

Effect of sodium‐glucose cotransporter 2 inhibitor, empagliflozin, and α‐glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes

Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study

Islet transplantation in Korea

Epidemic obesity and type 2 diabetes in Asia

Use of sodium‐glucose co‐transporter‐2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations

The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention

Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study

Prepregnancy smoking and the risk of gestational diabetes requiring insulin therapy

Diabetes duration and obesity matter in autologous mesenchymal stem/stromal cell transplantation in type 2 diabetes patients

Being caught in the perfect storm of a diabetes epidemic and the COVID‐19 pandemic: What should we do for our patients?

HDL-cholesterol, its variability and the risk of diabetes : a nationwide population-based study

Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes

Risk of developing chronic kidney disease in young-onset Type 2 diabetes in Korea

A Century of Progress in Diabetes Care with Insulin: A History of Innovations and Foundation for the Future

A 52‐week efficacy and safety study of enavogliflozin versus dapagliflozin as an add‐on to metformin in patients with type 2 diabetes mellitus: ENHANCE‐M extension study

Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record–Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial

Suchergebnisse filtern